Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-05-23 Sale | 2023-05-25 7:39 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 10,000 | $10 | $100,000 | 141,847 (Direct) | View |
2023-04-03 Sale | 2023-04-05 7:12 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $6.0856 | $124,407 | 337,823 (Indirect Direct) | View |
2023-03-06 Sale | 2023-03-08 5:45 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 5,000 | $7.7474 | $38,737 | 151,847 (Direct) | View |
2023-02-13 Sale | 2023-02-15 8:12 pm | Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. | 5,922 | $10.69 | $63,322 | 103,007 (Direct) | View |
2023-02-13 Sale | 2023-02-15 8:09 pm | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 7,506 | $10.69 | $80,259 | 1,034,681 (Indirect Direct) | View |
2023-02-13 Sale | 2023-02-15 8:07 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 4,871 | $10.33 | $50,338 | 292,846 (Indirect Direct) | View |
2023-02-13 Sale | 2023-02-15 8:04 pm | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 1,902 | $10.69 | $20,337 | 48,686 (Direct) | View |
2023-02-13 Sale | 2023-02-15 7:58 pm | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 1,794 | $10.69 | $19,183 | 239,187 (Direct) | View |
2023-02-13 Sale | 2023-02-15 7:56 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 1,660 | $10.69 | $17,750 | 156,847 (Direct) | View |
2022-12-21 Sale | 2022-12-23 7:00 pm | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 66,764 | $8.963 | $598,406 | 1,062,641 (Indirect Direct) | View |
2022-12-15 Sale | 2022-12-16 6:36 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 19,648 | $11.14 | $218,963 | 296,050 (Indirect Direct) | View |
2022-09-08 Sale | 2022-09-09 6:44 pm | Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. | 1,813 | $4.8731 | $8,835 | 108,929 (Direct) | View |
2022-07-29 Sale | 2022-08-02 9:47 pm | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 11,377 | $6.75 | $76,795 | 1,081,509 (Indirect Direct) | View |
2022-07-29 Sale | 2022-08-02 9:43 pm | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 2,959 | $6.75 | $19,973 | 48,921 (Direct) | View |
2022-07-29 Sale | 2022-08-02 9:42 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 10,375 | $6.6668 | $69,168 | 315,698 (Indirect Direct) | View |
2022-07-29 Sale | 2022-08-02 9:40 pm | Icosavax Inc. | ICVX | Richardson Charles E SVP, Technical Operations | 2,218 | $6.7501 | $14,972 | 165,168 (Direct) | View |
2022-07-29 Sale | 2022-08-02 9:37 pm | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 3,245 | $6.7501 | $21,904 | 239,314 (Direct) | View |
2022-07-29 Sale | 2022-08-02 9:34 pm | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 1,812 | $6.75 | $12,231 | 131,738 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-04-03 Exercise | 2023-04-05 7:12 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $1.04 | 337,823 (Direct) | View |
2023-04-03 Exercise | 2023-04-05 7:12 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $0 | 337,823 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 7:16 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 7:13 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. | 100,000 | $0 | 100,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 7:10 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 7:08 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 90,000 | $0 | 90,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 7:06 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 140,000 | $0 | 140,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 7:03 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 350,000 | $0 | 350,000 (Direct) | View |
2023-02-15 Exercise | 2023-02-16 8:00 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 10,677 | $1.04 | 1,462,608 (Direct) | View |
2023-02-15 Exercise | 2023-02-16 8:00 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 10,677 | $0 | 1,462,608 (Direct) | View |
2022-05-31 Ownership | 2023-02-14 5:22 pm | N/A N/A | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 1,667 | $5.77 | 50,588 (Direct) | View |
2022-05-31 Ownership | 2023-02-14 5:19 pm | N/A N/A | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 1,667 | $5.77 | 240,981 (Direct) | View |
2022-05-31 Ownership | 2023-02-14 5:15 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 1,667 | $5.77 | 297,717 (Direct) | View |
Ownership | 2023-02-14 5:15 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 0 | $0 | 297,717 (Indirect) | View |
2022-05-31 Ownership | 2023-02-14 5:02 pm | N/A N/A | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 1,667 | $5.77 | 158,507 (Direct) | View |
2023-01-30 Exercise | 2023-01-31 4:19 pm | N/A 2029-12-01 | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 25,102 | $0 | 159,351 (Direct) | View |
2023-01-30 Exercise | 2023-01-31 4:19 pm | N/A N/A | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 25,102 | $0.84 | 159,351 (Direct) | View |
2023-01-25 Exercise | 2023-01-27 5:02 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 10,678 | $1.04 | 1,501,246 (Direct) | View |
2023-01-25 Exercise | 2023-01-27 5:02 pm | N/A 2030-05-10 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 13,073 | $0 | 1,501,246 (Direct) | View |
2023-01-25 Exercise | 2023-01-27 5:02 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 2,395 | $0.84 | 1,501,246 (Direct) | View |
2022-12-23 Exercise | 2022-12-23 7:00 pm | N/A 2030-05-10 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 14,369 | $0 | 1,062,641 (Direct) | View |
2022-12-23 Exercise | 2022-12-23 7:00 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 14,369 | $0.84 | 1,062,641 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 7:08 pm | N/A 2032-11-09 | Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. | 88,900 | $0 | 88,900 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 7:05 pm | N/A 2032-11-09 | Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 6:58 pm | N/A 2032-11-09 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 82,580 | $0 | 82,580 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 6:53 pm | N/A 2032-11-09 | Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer | 100,000 | $0 | 100,000 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 6:50 pm | N/A 2032-11-09 | Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer | 82,580 | $0 | 82,580 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 6:43 pm | N/A 2032-11-09 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 277,146 | $0 | 277,146 (Direct) | View |
2022-02-18 Gift | 2022-08-02 9:42 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,000 | $0 | 315,698 (Indirect) | View |
2022-07-01 Exercise | 2022-07-06 6:53 pm | N/A 2030-05-10 | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 7,185 | $0 | 1,140,781 (Direct) | View |
2022-07-01 Exercise | 2022-07-06 6:53 pm | N/A N/A | Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer | 7,185 | $0.84 | 1,140,781 (Direct) | View |
2022-06-10 Option Award | 2022-06-14 5:10 pm | N/A 2032-06-09 | Icosavax Inc. | ICVX | Wassil Jim Director | 55,643 | $0 | 55,643 (Direct) | View |